A60 IMPROVING PROCESS IN THE EDMONTON PEDIATRIC INFLAMMATORY BOWEL DISEASE CLINIC: AN INFLIXIMAB INFUSION QUALITY IMPROVEMENT PROJECT

BACKGROUND: There is a growing body of literature demonstrating that sustained clinical remission using infliximab is related to adequate trough serum drug levels and inversely to the development of antibodies against the drug. Antibody formation typically occurs when serum drug levels fall too low;...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Can Assoc Gastroenterol
Hlavní autoři: Carroll, M W, Kluthe, C, Medvedev, P, Wine, E, Huynh, H Q
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2018
Témata:
Poster Presentations
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6507801/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jcag/gwy008.061
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky